DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Income Statement
USA - NASDAQ:DAWN - US23954D1090 - Common Stock
10.34 USD
-0.02 (-0.19%)
10.3 USD
-0.04 (-0.39%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 133.67M | 131.16M | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | 0 | 0 | -97.89M | |||
| Cost Of Goods | 14.11M | 5.28M | null | null | null | |||
| Gross Profit | 119.56M | 125.88M | null | null | null | |||
| Operating Expenses | 285.19M | 343.15M | 206.06M | 146.91M | 72.74M | |||
| Research and Development | 169.01M | 227.70M | 130.52M | 85.62M | 43.58M | |||
| Selling, General, and Administrative Expenses | 116.17M | 115.45M | 75.54M | 61.29M | 29.16M | |||
| Operating Income | -165.62M | -217.27M | -206.06M | -146.91M | -72.74M | |||
| Interest Income/Expense | 20.38M | 19.70M | 17.19M | 4.75M | 0 | |||
| Other Income/Expense | -36.00K | 1.22M | -40.00K | -20.00K | -20.00K | |||
| Non Recurring Items | null | 108.00M | null | null | null | |||
| Income Before Taxes | -145.28M | -88.35M | -188.92M | -142.18M | -72.75M | |||
| Income Tax | 6.47M | 7.14M | null | null | null | |||
| Net Income | -151.76M | -95.50M | -188.92M | -142.18M | -170.64M | |||
| EBITDA | -162.28M | -215.71M | -206.03M | -146.85M | -72.72M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.4769999999999999 | -1.0243 | -2.3682 | -2.17 | -4.62 | |||
| Non GAAP EPS | -1.47 | -1.78 | -2.38 | -2.17 | null | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.44% | 95.98% | N/A | N/A | N/A | |||
| Profit Margin | -113.53% | -72.81% | N/A | N/A | N/A | |||
| Operating Profit Margin | -123.90% | -165.65% | N/A | N/A | N/A | |||
All data in USD